Stomach Cancer Trial, Recruiting NCT06736847 Sponsor: Jichao Qin Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06736847
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years and younger than 85 years
  • People whose pre-surgery tissue testing confirmed a type of stomach cancer called gastric adenocarcinoma
  • People whose cancer was assessed before surgery as being at a certain stage (not too early and not spread to distant parts of the body, based on a standard staging system called AJCC 7th Edition) (confirm with trial site)
  • People who had a specific type of stomach surgery called distal gastrectomy, which removes part of the stomach, along with a thorough removal of nearby lymph nodes (D2 lymphadenectomy) and surrounding tissue (complete mesogastric excision)
  • People assessed as being in a general health category of low to moderate surgical risk (ASA class I, II, or III)
  • People who have given written consent to participate

Who may not be able to join:

  • People whose pre-surgery biopsy did not confirm the presence of cancer
  • People whose cancer was found to be at a very advanced stage or had already spread to other parts of the body (cT4b or M1)
  • People with a Body Mass Index (a measure of body weight relative to height) above 30 kg/m²
  • People who had the whole stomach removed or the upper part of the stomach removed (total or proximal gastrectomy)
  • People who received chemotherapy or radiation therapy before surgery
  • People who have had previous surgery in the upper part of the abdomen
  • People who have, or have had, another type of cancer at the same time
  • People who declined or refused the surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-197-068-25286

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jichao Qin
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Rate of lymph node metastasis and tumor deposit in the posterior gastric mesentery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov